Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT05430399 · RECRUITING
Trial details
- NCT number
- NCT05430399
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-21
- Primary completion
- 2025-06-01
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.